Effects of Etanercept and Minocycline in a rat model of spinal cord injury

European Journal of Pain

Volumn 13, Issue 7, 2009, Pages 673-681

  Marchand, Fabien ^a   Tsantoulas, Christoforos ^a   Singh, Dalbinder ^a   Grist, John ^a   Clark, Anna K ^a   Bradbury, Elizabeth J ^a   McMahon, Stephen B ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Microglia; Pain; Spinal cord injury; TNF

Indexed keywords

ETANERCEPT; MINOCYCLINE; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; EVOKED RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD HEMISECTION; SPINAL CORD INJURY; TREATMENT DURATION;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL COUNT; FUNCTIONAL LATERALITY; HOT TEMPERATURE; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, SPINAL; MALE; MICROGLIA; MINOCYCLINE; PAIN; PHYSICAL STIMULATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES; TUMOR NECROSIS FACTORS;

EID: 67649159074     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2008.08.001     Document Type: Article

References (60)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100 (2003) 7947-7952
2. Alano C.C., Kauppinen T.M., Valls A.V., and Swanson R.A. Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations. Proc Natl Acad Sci USA 103 (2006) 9685-9690
3. Berrocal Y.A., Pearse D.D., Andrade C.M., Hechtman J.F., Puentes R., and Eaton M.J. Increased spinal c-Fos expression with noxious and non-noxious peripheral stimulation after severe spinal contusion. Neurosci Lett 413 (2007) 58-62
4. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., et al. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp Neurol 204 (2007) 220-233
5. Calabrese L.H. Molecular differences in anticytokine therapies. Clin Exp Rheumatol 21 (2003) 241-248
6. Christensen M.D., Everhart A.W., Pickelman J.T., and Hulsebosch C.E. Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain 68 (1996) 97-107
7. Dhillon S., Lyseng-Williamson K.A., and Scott L.J. Etanercept: a review of its use in the management of rheumatoid arthritis. Drugs 67 (2007) 1211-1241
8. Finnerup N.B., and Jensen T.S. Spinal cord injury pain--mechanisms and treatment. Eur J Neurol 11 (2004) 73-82
9. Genovese T., Mazzon E., Crisafulli C., Di Paola R., Muia C., Bramanti P., et al. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury. J Pharmacol Exp Ther 316 (2006) 1006-1016
10. George A., Marziniak M., Schafers M., Toyka K.V., and Sommer C. Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-alpha, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin. Pain 88 (2000) 267-275
11. Gwak Y.S., Kang J., Leem J.W., and Hulsebosch C.E. Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats. J Neurosci Res 85 (2007) 2352-2359
12. Gwak Y.S., Tan H.Y., Nam T.S., Paik K.S., Hulsebosch C.E., and Leem J.W. Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J Neurotrauma 23 (2006) 1111-1124
13. Hains B.C., and Waxman S.G. Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26 (2006) 4308-4317
14. Hall E.D., and Springer J.E. Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1 (2004) 80-100
15. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
16. Hughes P.M., Botham M.S., Frentzel S., Mir A., and Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent. Glia 37 (2002) 314-327
17. Hulsebosch C.E. From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury. Curr Pharm Des 11 (2005) 1411-1420
18. Ji R.R., and Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE 2004 252 (2004) re 14
19. Koehler P.J., and Endtz L.J. The Brown-Sequard syndrome. True or false? Arch. Neurol 43 (1986) 921-924
20. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
21. Lindenlaub T., Teuteberg P., Hartung T., and Sommer C. Effects of neutralizing antibodies to TNF-alpha on pain-related behavior and nerve regeneration in mice with chronic constriction injury. Brain Res 866 1-2 (2000) 15-22
22. Lindenlaub T., and Sommer C. Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105 6 (2003) 593-602
23. Lindia J.A., McGowan E., Jochnowitz N., and Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6 (2005) 434-438
24. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat Rev Neurosci 6 (2005) 521-532
25. Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O'Connor K.A., et al. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 20 (2004) 2294-2302
26. Ohtori S., Takahashi K., Moriya H., and Myers R.R. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 29 (2004) 1082-1088
27. Owolabi S.A., and Saab C.Y. Fractalkine and minocycline alter neuronal activity in the spinal cord dorsal horn. FEBS Lett 580 (2006) 4306-4310
28. Pearse D.D., Pereira F.C., Stolyarova A., Barakat D.J., and Bunge M.B. Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages. Eur J Neurosci 20 (2004) 3387-3396
29. Peng X.M., Zhou Z.G., Glorioso J.C., Fink D.J., and Mata M. Tumor necrosis factor-alpha contributes to below-level neuropathic pain after spinal cord injury. Ann Neurol 59 (2006) 843-851
30. Pineau I., and Lacroix S. Proinflammatory cytokine synthesis in the injured mouse spinal cord: multiphasic expression pattern and identification of the cell types involved. J Comp Neurol 500 (2007) 267-285
31. Raghavendra V., Tanga F., and DeLeo J.A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306 (2003) 624-630
32. Reeve A.J., Patel S., Fox A., Walker K., and Urban L. Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur J Pain 4 3 (2000) 247-257
33. Schafers M., Geis C., Svensson C.I., Luo Z.D., and Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur J Neurosci 17 (2003) 791-804
34. Schafers M., Lee D.H., Brors D., Yaksh T.L., and Sorkin L.S. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J Neurosci 23 (2003) 3028-3038
35. Schafers M., Svensson C.I., Sommer C., and Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 23 (2003) 2517-2521
36. Scholz J., and Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 10 (2007) 1361-1368
37. Siddall P.J., Xu C.L., Floyd N., and Keay K.A. C-fos expression in the spinal cord of rats exhibiting allodynia following contusive spinal cord injury. Brain Res 851 (1999) 281-286
38. Sommer C., Lindenlaub T., Teuteberg P., Schafers M., Hartung T., and Toyka K.V. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res 913 (2001) 86-89
39. Sommer C., Schafers M., Marziniak M., and Toyka K.V. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst 6 (2001) 67-72
40. Sommer C., and Schäfers M. Painful mononeuropathy in C57BL/Wld mice with delayed wallerian degeneration: differential effects of cytokine production and nerve regeneration on thermal and mechanical hypersensitivity. Brain Res 784 1-2 (1998) 154-162
41. Stirling D.P., Khodarahmi K., Liu J., McPhail L.T., McBride C.B., Steeves J.D., et al. Minocycline treatment reduces delayed oligodendrocyte death, attenuates axonal dieback, and improves functional outcome after spinal cord injury. J Neurosci 24 (2004) 2182-2190
42. Svensson C.I., Schafers M., Jones T.L., Powell H., and Sorkin L.S. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett 379 (2005) 209-213
43. Sweitzer S., Martin D., and DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
44. Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain 13 (2008) 263-272
45. Tanaka T., Minami M., Nakagawa T., and Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 78 (2004) 463-469
46. Tikka T.M., and Koistinaho J.E. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166 (2001) 7527-7533
47. Tsuda M., Shigemoto-Mogami Y., Koizumi S., Mizokoshi A., Kohsaka S., Salter M.W., et al. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature 424 (2003) 778-783
48. Uçeyler N., Rogausch J.P., Toyka K.V., and Sommer C. Differential expression of cytokines in painful and painless neuropathies. Neurology 69 1 (2007) 42-49
49. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20 (2004) 1150-1160
50. Wang X., Arcuino G., Takano T., Lin J., Peng W.G., Wan P., et al. P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10 (2004) 821-827
51. Watkins L.R., Milligan E.D., and Maier F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
52. Watkins L.R., Milligan E.D., and Maier S.F. Spinal cord glia: new players in pain. Pain 93 (2001) 201-205
53. Yang L., Jones N.R., Blumbergs P.C., Van Den H.C., Moore E.J., Manavis J., et al. Severity-dependent expression of pro-inflammatory cytokines in traumatic spinal cord injury in the rat. J Clin Neurosci 12 (2005) 276-284
54. Yezierski R.P. Spinal cord injury: a model of central neuropathic pain. Neurosignals 14 (2005) 182-193
55. Zelenka M., Schafers M., and Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116 (2005) 257-263
56. Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., and Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci 27 45 (2007) 12396-12406
57. Zhang S.C., Goetz B.D., and Duncan I.D. Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia 41 (2003) 191-198
58. Zhao P., Waxman S.G., and Hains B.C. Extracellular signal-regulated kinase-regulated microglia-neuron signaling by prostaglandin E2 contributes to pain after spinal cord injury. J Neurosci 27 (2007) 2357-2368
59. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y., Ona V., Li M., et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78
60. Zimmerman A. Committee for research and ethical issues of the IASP. Pain 16 (1983) 109-110